Detalhe da pesquisa
1.
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.
Front Pharmacol
; 15: 1380000, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38887559